Among the most common diabetes mellitus medications, metformin stands out with prescription to 80% of patients, followed by the group comprising SGLT-2 inhibitors (19%), DPP-4 inhibitors (14%), GLP-1 RA (7%) and insulin (8%). This evidence concerns the gene INS and diabetes mellitus.